HHS urged a federal court to dismiss lawsuits from Eli Lilly, Bristol Myers Squibb and Novartis seeking to implement 340B rebate models.

Trump Administration Opposes Unilateral Drugmaker 340B Rebates in First Legal Filing on Issue

March 18, 2025 William Newton, Associate Editor/Senior Writer Views

In the Trump administration’s first legal filing on drugmaker 340B rebates, the U.S. Department of Health and Human Services (HHS) [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!